{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:19:15Z","timestamp":1786994355670,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015279","name":"Osaka Foundation for Promotion of Fundamental Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","award":["202403011355558406"],"award-info":[{"award-number":["202403011355558406"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"publisher","award":["19K23958"],"award-info":[{"award-number":["19K23958"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008644","name":"Japan Diabetes Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008644","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008880","name":"Kanae Foundation for the Promotion of Medical Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013236","name":"MSD Life Science Foundation, Public Interest Incorporated Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013236","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K16362"],"award-info":[{"award-number":["21K16362"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K15386"],"award-info":[{"award-number":["23K15386"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.molmet.2026.102324","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:39:47Z","timestamp":1769733587000},"page":"102324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Sodium-glucose cotransporter-specific substrate \u03b1MG stimulates endogenous glucagon secretion and ameliorates obesity-associated metabolic disorders in mice"],"prefix":"10.1016","volume":"105","author":[{"given":"Takayoshi","family":"Suga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Tabei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ikeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Tojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kakizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Fujitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Uraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-8740","authenticated-orcid":false,"given":"Tadahiro","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.molmet.2026.102324_bib1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.molmet.2026.102324_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.molmet.2026.102324_bib3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1463-1326.2010.01256.x","article-title":"The therapeutics of lifestyle management on obesity","volume":"12","author":"Dyson","year":"2010","journal-title":"Diabetes Obes Metabol"},{"issue":"2","key":"10.1016\/j.molmet.2026.102324_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.molmet.2026.102324_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.molmet.2026.102324_bib6","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2337\/dc07-0048","article-title":"Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial","volume":"30","author":"Pi-Sunyer","year":"2007","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.molmet.2026.102324_bib7","first-page":"581","article-title":"Comparison of the effects of glucagon and atropine sulfate on gastric emptying","volume":"70","author":"Chernish","year":"1978","journal-title":"Am J Gastroenterol"},{"issue":"6 Pt 2","key":"10.1016\/j.molmet.2026.102324_bib8","first-page":"R975","article-title":"Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men","volume":"262","author":"Geary","year":"1992","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.molmet.2026.102324_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0031-9384(77)90218-9","article-title":"Decreased feeding in rats following hepatic-portal infusion of glucagon","volume":"19","author":"Martin","year":"1977","journal-title":"Physiol Behav"},{"issue":"2 Pt 2","key":"10.1016\/j.molmet.2026.102324_bib10","first-page":"R501","article-title":"Glucagon in physiological concentrations stimulates brown fat thermogenesis in vivo","volume":"261","author":"Billington","year":"1991","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.molmet.2026.102324_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3803\/EnM.2024.1911","article-title":"Glucagon: physiological and pharmacological functions and pathophysiological significance in type 2 diabetes","volume":"39","author":"Kitamura","year":"2024","journal-title":"Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.molmet.2026.102324_bib12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/en.2011-1979","article-title":"Minireview: Glucagon in stress and energy homeostasis","volume":"153","author":"Jones","year":"2012","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.molmet.2026.102324_bib13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0014-4800(84)90049-2","article-title":"Suppression of weight gain by glucagon in obese Zucker rats","volume":"40","author":"Chan","year":"1984","journal-title":"Exp Mol Pathol"},{"issue":"3","key":"10.1016\/j.molmet.2026.102324_bib14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1152\/jappl.1957.11.3.419","article-title":"Effect of glucagon on food intake and body weight in man","volume":"11","author":"Schulman","year":"1957","journal-title":"J Appl Physiol"},{"issue":"4","key":"10.1016\/j.molmet.2026.102324_bib15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0016-5107(75)73837-3","article-title":"The role of glucagon in endoscopic cholangiopancreatography","volume":"21","author":"Silvis","year":"1975","journal-title":"Gastrointest Endosc"},{"issue":"11","key":"10.1016\/j.molmet.2026.102324_bib16","article-title":"Hypoaminoacidemia underpins glucagon-mediated energy expenditure and weight loss","volume":"3","author":"Hope","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.molmet.2026.102324_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102073","article-title":"Characterization of LY3324954 a long-acting glucagon-receptor agonist","volume":"91","author":"Roell","year":"2025","journal-title":"Mol Metabol"},{"issue":"2\u20133","key":"10.1016\/j.molmet.2026.102324_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mam.2012.11.002","article-title":"Glucose transport families SLC5 and SLC50","volume":"34","author":"Wright","year":"2013","journal-title":"Mol Aspect Med"},{"issue":"1","key":"10.1016\/j.molmet.2026.102324_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrneph.2016.170","article-title":"Renal, metabolic and cardiovascular considerations of SGLT2 inhibition","volume":"13","author":"DeFronzo","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.molmet.2026.102324_bib20","doi-asserted-by":"crossref","first-page":"F188","DOI":"10.1152\/ajprenal.00518.2013","article-title":"Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia","volume":"306","author":"Rieg","year":"2014","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"10.1016\/j.molmet.2026.102324_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/db11-1029","article-title":"Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion","volume":"61","author":"Gorboulev","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2026.102324_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmet.2018.10.009","article-title":"SGLT1 in pancreatic \u03b1 cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels","volume":"19","author":"Suga","year":"2019","journal-title":"Mol Metabol"},{"issue":"3","key":"10.1016\/j.molmet.2026.102324_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11060-018-2823-7","article-title":"Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas","volume":"138","author":"Kepe","year":"2018","journal-title":"J Neuro Oncol"},{"issue":"467","key":"10.1016\/j.molmet.2026.102324_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat5933","article-title":"Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma","volume":"10","author":"Scafoglio","year":"2018","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.molmet.2026.102324_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0329094","article-title":"Liver-specific glucagon dysfunction promotes PP-cell hyperplasia and formation of glucagon and PP double-positive cells","volume":"20","author":"Nakagawa","year":"2025","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.molmet.2026.102324_bib26","doi-asserted-by":"crossref","first-page":"E1358","DOI":"10.1152\/ajpendo.00412.2009","article-title":"Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice","volume":"297","author":"Moriya","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.molmet.2026.102324_bib27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cmet.2016.08.020","article-title":"Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes","volume":"24","author":"Segerstolpe","year":"2016","journal-title":"Cell Metab"},{"issue":"11","key":"10.1016\/j.molmet.2026.102324_bib28","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.molmet.2026.102324_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.100930","article-title":"CREBH improves diet-induced obesity, insulin resistance, and metabolic disturbances by FGF21-Dependent and FGF21-Independent mechanisms","volume":"23","author":"Satoh","year":"2020","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.molmet.2026.102324_bib30","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1210\/jc.2006-1318","article-title":"Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state","volume":"92","author":"Jocken","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.molmet.2026.102324_bib31","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.cmet.2017.05.006","article-title":"Amino acid transporter Slc38a5 controls Glucagon receptor inhibition-induced pancreatic \u03b1 cell hyperplasia in mice","volume":"25","author":"Kim","year":"2017","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.molmet.2026.102324_bib32","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1073\/pnas.0237106100","article-title":"Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice","volume":"100","author":"Gelling","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.molmet.2026.102324_bib33","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.2337\/db11-1605","article-title":"Liver-specific disruption of the murine glucagon receptor produces \u03b1-cell hyperplasia: evidence for a circulating \u03b1-cell growth factor","volume":"62","author":"Longuet","year":"2013","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"10.1016\/j.molmet.2026.102324_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1467-789X.2012.01041.x","article-title":"Adaptive thermogenesis in human body weight regulation: more of a concept than a measurable entity?","volume":"13","author":"Dulloo","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/j.molmet.2026.102324_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101633","article-title":"BI 456906: discovery and preclinical pharmacology of a novel GCGR\/GLP-1R dual agonist with robust anti-obesity efficacy","volume":"66","author":"Zimmermann","year":"2022","journal-title":"Mol Metabol"},{"issue":"10","key":"10.1016\/j.molmet.2026.102324_bib36","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","article-title":"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial","volume":"28","author":"Garvey","year":"2022","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.molmet.2026.102324_bib37","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00125-022-05715-4","article-title":"Management of type 2 diabetes with the dual GIP\/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis","volume":"65","author":"Karagiannis","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2026.102324_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol Metabol"},{"issue":"10","key":"10.1016\/j.molmet.2026.102324_bib39","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.2337\/db09-0278","article-title":"Glucagon-like peptide 1\/glucagon receptor dual agonism reverses obesity in mice","volume":"58","author":"Pocai","year":"2009","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.molmet.2026.102324_bib40","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/hep.28962","article-title":"A novel glucagon-like peptide 1\/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice","volume":"65","author":"Valdecantos","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2026.102324_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm.3761","article-title":"A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents","volume":"21","author":"Finan","year":"2015","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.molmet.2026.102324_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105296","article-title":"Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells","volume":"25","author":"Elmelund","year":"2022","journal-title":"iScience"},{"issue":"11","key":"10.1016\/j.molmet.2026.102324_bib43","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.cmet.2022.10.001","article-title":"The past, present, and future physiology and pharmacology of glucagon","volume":"34","author":"Capozzi","year":"2022","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.molmet.2026.102324_bib44","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2337\/db12-1116","article-title":"Fibroblast growth factor 21 mediates specific glucagon actions","volume":"62","author":"Habegger","year":"2013","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.molmet.2026.102324_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/dom.12585","article-title":"Glucagon increases energy expenditure independently of brown adipose tissue activation in humans","volume":"18","author":"Salem","year":"2016","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2026.102324_bib46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molmet.2019.01.011","article-title":"The brown adipose tissue glucagon receptor is functional but not essential for control of energy homeostasis in mice","volume":"22","author":"Beaudry","year":"2019","journal-title":"Mol Metabol"},{"issue":"6","key":"10.1016\/j.molmet.2026.102324_bib47","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jhep.2025.06.011","article-title":"Glucagon controls obesity-specific energy expenditure via persistent cAMP\/PKA signaling","volume":"83","author":"Long","year":"2025","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.molmet.2026.102324_bib48","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.2337\/db06-0531","article-title":"Sodium-coupled glucose cotransporters contribute to hypothalamic glucose sensing","volume":"55","author":"O\u2019Malley","year":"2006","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.molmet.2026.102324_bib49","doi-asserted-by":"crossref","first-page":"C240","DOI":"10.1152\/ajpcell.00317.2012","article-title":"Regional distribution of SGLT activity in rat brain in vivo","volume":"304","author":"Yu","year":"2013","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"10.1016\/j.molmet.2026.102324_bib50","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2337\/diabetes.52.5.1147","article-title":"A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line","volume":"52","author":"Gribble","year":"2003","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.molmet.2026.102324_bib51","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00125-012-2585-2","article-title":"Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion","volume":"55","author":"Parker","year":"2012","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.molmet.2026.102324_bib52","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2337\/db14-0807","article-title":"Molecular mechanisms of glucose-stimulated GLP-1 secretion from perfused rat small intestine","volume":"64","author":"Kuhre","year":"2015","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.molmet.2026.102324_bib53","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.2337\/db17-0058","article-title":"Mechanisms controlling glucose-induced GLP-1 secretion in human small intestine","volume":"66","author":"Sun","year":"2017","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.molmet.2026.102324_bib54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12933-019-0889-y","article-title":"Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity","volume":"18","author":"Yoshii","year":"2019","journal-title":"Cardiovasc Diabetol"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877826000086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877826000086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:30:01Z","timestamp":1781235001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877826000086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":54,"alternative-id":["S2212877826000086"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2026.102324","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium-glucose cotransporter-specific substrate \u03b1MG stimulates endogenous glucagon secretion and ameliorates obesity-associated metabolic disorders in mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2026.102324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"102324"}}